Search

everythinglearnresearchcommunity

for

Search:↓

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Pimecrolimus cream is not effective for treating alopecia areata.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Hair gels may cause split ends in children.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

CTE can distort results in hair growth trials, so exclude it carefully.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Apremilast shows promise for several skin conditions but needs more research.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

MPZL3 is crucial for seborrheic dermatitis development.

Various drugs caused different skin reactions, including allergic and inflammatory responses.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Cetuximab can cause excessive eyelash growth.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Dupilumab for eczema may cause hair loss.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.